Aging reshapes breast tissue, boosting cancer risk via epigenetic and immune shifts. Key insights for clinical practice.

Funding from Cancer Prevention and Research Institute of Texas has brought more than 324 distinguished cancer researchers to Texas.

Scientists in Manchester working to understand why some breast cancers come back years later and form incurable secondary ...

A high omega-3, low omega-6 diet with fish oil led to a significant reduction in a biomarker for prostate cancer progression ...

Two Breast Cancer Now research teams, one of which is led by scientists at the University of Sheffield, will receive £500,000 ...

Human health is strongly intertwined with the health of the microbiome. A large number of studies have shown that the human ...

Researchers propose that CNDP2-mediated cooperation can be an effective and specific target for cancer treatment.

Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a leader in macrophage-focused therapeutics, today announced that Michael Klichinsky, PharmD, PhD, Co-founder and Chief ...

Dr. Rousseau to lead clinical development as Pheast advances PHST001, a novel anti-CD24 macrophage checkpoint inhibitor, into ...

The Penn physician-researcher has received more funding to advance his 'Trojan horse' for attacking gastroesophageal cancer.

Solid tumors are difficult to treat due to their heterogeneity and limited blood supply, which restrict the effective ...